CART (55-102) (HUMAN)
CAS214050-22-3
CART (55-102) (HUMAN) (CAS 214050-22-3, C225H365N65O65S7) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 214050-22-3
- Formula
- C225H365N65O65S7
- Mol. weight
- 5245.1 g/mol
Chemical Specifications
Identifiers
| CAS number | 214050-22-3 |
|---|---|
| Product name | CART (55-102) (HUMAN) |
| Synonyms | CART PEPTIDE (AA 55-102), HUMAN; CART (HUMAN, 55-102); CART (55-102); H-VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYA-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHELEU-LEU-LYS-CYS- |
| Molecular formula | C225H365N65O65S7 |
| Molecular weight | 5245.1 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of CART (55-102) (HUMAN)?
The CAS Registry Number of CART (55-102) (HUMAN) is 214050-22-3. CART (55-102) (HUMAN) is also known as CART PEPTIDE (AA 55-102), HUMAN; CART (HUMAN, 55-102); CART (55-102).
What is the molecular formula and molecular weight of CART (55-102) (HUMAN)?
The molecular formula of CART (55-102) (HUMAN) is C225H365N65O65S7, and its molecular weight is 5245.1 g/mol.
How can I request a quotation for CART (55-102) (HUMAN)?
Send an inquiry for CART (55-102) (HUMAN) (CAS 214050-22-3) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for CART (55-102) (HUMAN)
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.